|
TNF-like ligand 1A (TL1A), a member of the tumor necrosis factor (TNF) superfamily, plays a crucial role in the regulation of immune responses and is significantly involved in the pathogenesis of various autoimmune and inflammatory diseases. Recent advancements in TL1A inhibitors have the potential to revolutionize the treatment of autoimmune diseases such as inflammatory bowel disease (IBD), psoriasis, and rheumatoid arthritis. Clinical trials have demonstrated that TL1A monoclonal antibody inhibitors significantly enhance remission rates and treatment durability. Sino Biological offers a broad selection of recombinant TL1A proteins with various tags and multiple species, facilitating further research into autoimmune diseases.
|
